Massoud Houshmand

Massoud Houshmand

Auto-generated profile, based on publicly available information

Massoud Houshmand

National Institute of Genetic Engineering and Biotechnology (NIGEB)

Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2006 in Journal of the Neurological Sciences
Verified
Journal Article
Closed access
PDF file
HKHassan H. Kumleh
Hassan H. Kumleh
GRGholam H. Riazi
Gholam H. Riazi
MHMassoud Houshmand
Massoud Houshmand
MSMohammad H. Sanati
Mohammad H. Sanati
KGKourosh Gharagozli
Kourosh Gharagozli
MSMehdi Shafa
Mehdi Shafa

21 December 2006 in Cellular and Molecular Neurobiology
Verified
Journal Article
Closed access
PDF file
FFFarzaneh Fesahat
Farzaneh Fesahat
MHMassoud Houshmand
Massoud Houshmand
MPMehdi Shafa Shariat Panahi
Mehdi Shafa Shariat Panahi
KGKurosh Gharagozli
Kurosh Gharagozli
FMFarzaneh Mirzajani
Farzaneh Mirzajani

30 April 2006 in Mitochondrion
Verified
Journal Article
Closed access
MHMassoud Houshmand
Massoud Houshmand
MPMehdi Shafa Shariat Panahi
Mehdi Shafa Shariat Panahi
SNShahriar Nafisi
Shahriar Nafisi
ASAkbar Soltanzadeh
Akbar Soltanzadeh
FAFawziah M. Alkandari
Fawziah M. Alkandari

1 December 2005 in Multiple Sclerosis Journal
Verified
Journal Article
Closed access
MHM Houshmand
M Houshmand
MSM H Sanati
M H Sanati
FBF Babrzadeh
F Babrzadeh
AAA Ardalan
A Ardalan
MTM Teimori
M Teimori
JLJ Lotfi
J Lotfi
Background: Multiple sclerosis (MS) is an immunological inflammatory disease of the central nervous system (CNS) which is chronically observed in young adults. On the basis of earlier studies, potential relatedness between MS and mitochondrial DNA (mtDNA) mutations was postulated. Materials and methods: 246 individuals were screened using the PCR-RFLP method, including 70 MS patients examined for mitochondrial haplogroups BM, J, K and M and 176, 149 and 70 normal controls examined for haplogroups BM and M, J and K, respectively. Results and discussion: Our analysis revealed a relatively high proportion of haplogroup BM in MS patients (∼26%) compared to normal controls (∼13%). In addition, a slightly significant increase of MS patients of haplogroup J (20% in MS patients versus 9.39% in normal controls at P-0.049), while haplogroups M and K did not show contribution to MS contingency (2.85 and 2.27%, respectively at P-1.000 in haplogroup M and 12.85 and 7.14% respectively at P-0.399 in haplogroup K).

1 September 2010
Verified
Journal Article
Closed access
RMReza Mirfakhraie
Reza Mirfakhraie
FMFarzaneh Mirzajani
Farzaneh Mirzajani
SKSayed Mahdi Kalantar
Sayed Mahdi Kalantar
MMMaryam Montazeri
Maryam Montazeri
NSNasser Salsabili
Nasser Salsabili
MHMassoud Houshmand
Massoud Houshmand

1 March 2006 in Cellular and Molecular Neurobiology
Verified
Journal Article
Closed access
PDF file
HKHassan Hassani- Kumleh
Hassan Hassani- Kumleh
MHMassoud Houshmand
Massoud Houshmand
MPMehdi Shafa Shariat Panahi
Mehdi Shafa Shariat Panahi
GRGholamhossein Riazi
Gholamhossein Riazi
MSMohammad Hossein Sanati
Mohammad Hossein Sanati
MGMojdeh Ghabaee
Mojdeh Ghabaee